| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.6 / 5 (539) | Istanbul, Turkey | 29+ years | Immunotherapy, targeted therapy, systemic chemotherapy | HER2-negative and aggressive breast cancer | Clinic offers multidisciplinary tumor board reviews with ESMO-certified specialists. Uses immunotherapy combined with PET-CT staging for personalized treatment plans. Affiliated with Johns Hopkins Medicine. | Planetree's Gold Certificate, International Accreditation System for Interventional Oncology Services (IASIOS) | ||
| #2 | 4.6 / 5 (430) | Istanbul, Turkey | — | — | Immunotherapy, chemotherapy, targeted therapy, PET-CT for treatment evaluation | Metastatic breast cancer with wide dissemination | Follows international NCCN and ESMO protocols, offers personalized treatment plans with post-therapy PET-CT evaluation, and has a high patient recommendation rate of 91%. | International Organization for Standardization, Joint Commission International | |
| #3 | 4.5 / 5 (171) | Tel Aviv, Israel | 41+ years34,000+ treatments | Immunotherapy, hormonal therapy, chemotherapy, biotherapy, radiotherapy, lumpectomy, mastectomy | Metastatic breast cancer patients | Achieves a 90% success rate in metastatic breast cancer treatment. Uses a multidisciplinary approach with advanced techniques like immunotherapy and genetic testing. | World's Best Smart Hospitals 2021 by Newsweek, World's Best Hospitals 2021 by Newsweek | ||
| #4 | 4.5 / 5 (262) | Istanbul, Turkey | 20+ years | Colonoscopy, Biochemical blood analysis | — | — | Joint Commission International , Turkish Medical Association (Türk Tabıplerı Bırliği) | ||
| #5 | 4.9 / 5 (59) | Istanbul, Turkey | — | — | MRI of one area, PET/CT | — | — | Turkish Medical Association, International Health Tourism Authorization Certificate | |
| #6 | 4.7 / 5 (492) | Barcelona, Spain | 41+ years23,000+ treatments | Immunotherapy for breast cancer, checkpoint inhibitors (atezolizumab, pembrolizumab), combination therapies, clinical trial evaluations | Personalized breast cancer immunotherapy | Led by Dr. Agusti Barnadas Molins, a specialist with 35+ years in breast cancer and over 130 publications. The clinic offers advanced diagnostics like PD-L1 and TMB testing, and provides personalized treatment plans based on tumor genetics. | Joint Commission International , European Foundation for Quality Management | ||
| #7 | 5.0 / 5 (3) | Madrid, Spain | — | — | Genetic screening, Consultation with an oncologist | — | — | Joint Commission International , International Organization for Standardization | |
| #8 | 4.6 / 5 (71) | Milan, Italy | 21+ years8,000+ treatments | Immunotherapy for breast cancer, clinical trials for immunotherapies | Breast cancer with immune system involvement | Head of breast cancer group leads immunotherapy research, with over 100 clinical trials conducted. 12,000 cancer patients treated annually, including complex breast cancer cases. | Scientific Institute for Research and Healthcare Accrediatation, World's Best Hospitals 2021 by Newsweek | ||
| #9 | 4.6 / 5 (175) | Vienna, Austria | 44+ years | Consultation with an oncologist | — | — | World's Best Hospitals 2021 by Newsweek, International Organization for Standardization | ||
| #10 | 4.7 / 5 (161) | Istanbul, Turkey | — | — | Thyroid function tests (including T3, T4, TSH), Mammography | Personalized immunotherapy planning via multidisciplinary oncology councils | Multidisciplinary oncology council designs personalized immunotherapy plans integrating targeted therapy and chemotherapy. Oncology department led by professors, JCI-accredited hospital. | International Organization for Standardization, Joint Commission International |